Thanh Nguyen ๐บ๐ฆ
@NguyenThanhMD
Followers
9K
Following
11K
Media
112
Statuses
5K
Director, Interventional Neurology @The_BMC; Professor @BUMedicine; President @SVINSociety; Associate Editor @StrokeAHA_ASA; Mom, pianist, tennis fan
Boston, MA
Joined January 2018
SVIN's Women in Neurology Committee will be attending the upcoming Annual Meeting! Friday morning will host the WIN Breakfast Symposia and feature an empowering session with speaker Meggan Teague designed to help women in neurology confidently advocate for themselves and their
0
3
10
Congrats and thank you to Dr. Yazan Radaideh and the entire @UFHealthJax team for enrolling their first patient and the 127th patient overall in the #PICASSO trial! ๐ @oozaidat @samialkasab @NguyenThanhMD #stroke #ClinicalTrial
0
1
2
Honored to present at #WSC2025 on the risks & benefits of emergent carotid stenting in tandem occlusions โ sharing data from our CERES-TANDEM registry. Grateful to moderators @ArKatsanos & Carol Xiong, and co-speakers @amrsarrajMD & @NguyenThanhMD
@WorldStrokeEd
1
7
33
Biomarkers of Impaired Distal Perfusion in ICAS In our latest #BloggingStroke post, @JohannaSeidenMD discusses #Stroke article by @ShadiYaghi2 et al., presented today at #WSC2025. #AHAJournals @WorldStrokeOrg
https://t.co/X4ZqcMoWsm
ahajournals.org
1
8
16
Thank you @oozaidat and the Picasso team for having us. @ShailThankiMD, @OchsnerHealth @NeuroIRdoc @svinsociety
Congrats and thank you to Dr. @ShailThankiMD, Dr. @Mo_majali91, Dr. Alicia Nicklas, and the entire @OchsnerHealth team for enrolling the 126th patient in the #PICASSO trial! ๐ @oozaidat @samialkasab @NguyenThanhMD #stroke #ClinicalTrial
0
2
6
Early recurrence in medically treated patients with symptomatic ICAS is driven by impaired distal perfusion. Happy to share that the BIORISK ICAS study was presented at WSC and published in stroke. I am grateful for our collaborators from across the world. https://t.co/wAnHhGvUPp
2
30
86
The stroke field had major developments since 1993 when the TOAST criteria were proposed. We need move on to a different system that incorporates new mechanisms/tools/testing and standardizes the minimum workup. Introducing ISPS25 #stroke #WSC25 #meded
https://t.co/Tv3xYXBznX
5
76
196
Congrats and thank you to Dr. @ShailThankiMD, Dr. @Mo_majali91, Dr. Alicia Nicklas, and the entire @OchsnerHealth team for enrolling the 126th patient in the #PICASSO trial! ๐ @oozaidat @samialkasab @NguyenThanhMD #stroke #ClinicalTrial
0
3
4
5/ Check out the article, "Building Mechanical Thrombectomy Capacity: Training Vascular Neurologists in Low- and Middle-Income Countries." https://t.co/UIPIJvR2wh
#AHAJournals #WSC2025 @Ahmednasr_Neuro @NguyenThanhMD @almuftifawaz @WorldStrokeOrg
ahajournals.org
0
2
4
Patient 3๏ธโฃ0๏ธโฃ0๏ธโฃ enrolled into #EASITOC trial in Calgary! #tandemstroke
@ChumNeuro
@chumontreal
1
4
22
Countdown to #WSC25 in Barcelona. Excited to share the primary results of TRIMIS. EVT in mild stroke @StrokeMiami @NguyenThanhMD @ShadiYaghi2#luispaixao @ShuLiqi ๐ Thu, Oct 23 | ๐ 17:15 | ๐ Room 115
0
6
34
๐ IA tPA post thrombectomy: "Taking CHOICE, ANGEL-TNK, and PEARL together, results suggest IA thrombolysis with TNK or tPA after thrombectomy in pts with >50% reperfusion (but perhaps not >90% reperfusion) is beneficial" ๐ ๐ช https://t.co/rp2Kii5BTQ
jamanetwork.com
Neurological disorders are the leading cause of disease burden worldwide. Stroke is the single largest contributor to that burden, and the second leading cause of global mortality.1 Approximately...
0
16
48
Join us at #SVIN2025 for a deep dive into current and emerging strategies for treating intracranial atherosclerotic disease. Register at https://t.co/vbMU2K7Dpj
@ramifakihmd @TareqKass @STateshimaMD @samialkasab
#StrokeCare #NeuroIR #SVIN #SVIN25 #SVINAnnualMeeting
0
8
22
Explore the latest in venous interventions: CSF leak repair, IIH stenting, venous approaches for endovascular procedures, and more. Join All in Vein at #SVIN2025 โ a must-see for neurointerventionalists. Register at https://t.co/qroHYw9LOI
@WaldoGuerrero82 @AbdalkaderMD
0
15
32
Congrats and thank you to Dr. @evanluthermd, Dr. Russell Cerejo, Dr. Scott Ruskin, Dr. @romilsingh1892, Dr. Seung Jeong, Dr. Andrew Ku, and the rest of the @AHNtoday team for enrolling the 124th patient in the #PICASSO trial! #ClinicalTrial @oozaidat @samialkasab @NguyenThanhMD
0
2
4
Donโt miss our upcoming WebNIR on October 22 - HiPoint in the Real World: Proven Techniques for the Monopoint Approach ๐ง https://t.co/qPDQbWh72Y Hear from Dr. Dan Tonetti and Dr. James Caldwell as they discuss real-world experience, clinical outcomes, and evolving techniques
0
4
11